Due to its unique ability to bind with CB2 receptors, Beta-caryophyllene has potent anti-inflammatory, antimicrobial, antibacterial, and antioxidant properties. It is known to help relieve anxiety and pain, reduce cholesterol, prevent Osteoporosis, and treat seizures BCP was found to elicit a full agonist action on cannabinoid type 2 (CB2) receptors, a G-protein coupled receptor representing important therapeutic target in several diseases. Activation of CB2 receptors notably appeared devoid of psychotropic adverse effect of cannabinoids contrary to the CB1 receptors. In addition, it activates peroxisome proliferated activator receptors (PPARs) isoforms; PPAR-α &-γ and inhibits pathways triggered by the activation of toll like receptor complex; CD14/TLR4/MD2, reduce immuneinflammatory processes and exhibit synergy with µ-opioid receptor dependent pathways. Additionally, it found as potent antagonist of homomeric nicotinic acetylcholine receptors (α7-nAChRs) and devoid of effects mediated by serotonergic and GABAergic receptors. It also modulates numerous molecular targets by altering their gene expression, signaling pathways or through direct interaction. Various pharmacological activities such as cardioprotective, hepatoprotective, gastroprotective, neuroprotective, nephroprotective, antioxidant, anti-inflammatory, antimicrobial and immune-modulator have been reported in experimental studies. It has shown potent therapeutic promise in neuropathic pain, neurodegenerative and metabolic diseases.

Can be a novel candidate for various pathologies considering the polypharmacological and multifaceted therapeutic properties potential along with favorable oral bioavailability, lipophilicity and physicochemical properties.

https://pubmed.ncbi.nlm.nih.gov/26965491/

D-limonene is considered to have fairly low toxicity. It has been tested for carcinogenicity in mice and rats. Although initial results showed d-limonene increased the incidence of renal tubular tumors in male rats, female rats and mice in both genders showed no evidence of any tumor. Subsequent studies have determined how these tumors occur and established that d-limonene does not pose a mutagenic, carcinogenic, or nephrotoxic risk to humans. In humans, d-limonene has demonstrated low toxicity after single and repeated dosing for up to one year. Being a solvent of cholesterol, d-limonene has been used clinically to dissolve cholesterol-containing gallstones. Because of its gastric acid neutralizing effect and its support of normal peristalsis, it has also been used for relief of heartburn and gastroesophageal reflux (GERD). D-limonene has well-established chemopreventive activity against many types of cancer. Evidence from a phase I clinical trial demonstrated a partial response in a patient with breast cancer and stable disease for more than six months in three patients with colorectal cancer.

https://pubmed.ncbi.nlm.nih.gov/18072821

https://www.healthline.com/nutrition/d-limonene#safety-and-side-effects

Myrcia sphaerocarpa, a medicinal shrub from Brazil traditionally used to treat diabetes, diarrhea, dysentery, and hypertension (Ulbricht, 2011). The main reported biological properties of β-myrcene—anxiolytic, antioxidant, anti-ageing, anti-inflammatory, analgesic properties—are discussed, with the mechanisms of activity. Here we also discuss recent data regarding the safety of β-myrcene. Overall, β-myrcene has shown promising health benefits in many animal studies. However, studies conducted in humans is lacking. In the future, there is potential for the formulation and production of non-alcoholic beers, functional foods and drinks, and cannabis extracts (low in THC) rich in β-myrcene.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326332/

B-myrcene is a natural compound with a stellar safety profile which could significantly improve immune functions, as well as decrease pain sensation in patients suffering from inflammatory as well as chronic pain. Given the known anti-inflammatory and antinociceptive effects of cannabis, it is important to discern the qualities that can provide the correct terpene synergy to manage different disorders such as ostheoarthritis, neuropathic pain or dermatitis. (2,21,22) Some cannabis strain more than others contain high levels of myrcene, usually those with more “sedative” effects, which, by the recreational world, have been called “indica plants”. Although the mechanism of function of myrcene is not fully understood yet, it is evident its promising role in the treatment of inflammation and pain. Better understanding of myrcene interactions within the cannabis plant and its clinical effect in humans may contribute to the developing of specific cannabis genetics to target at best inflammatory disorders.

https://www.fundacion-canna.es/en/anti-inflammatory-anti-nociceptive-properties-v-myrcene

Linalool’s analgesic and anti-inflammatory properties may contribute to pain relief when combined with other cannabinoids present in medical cannabis. Patients suffering from arthritis, migraines, or neuropathic pain may find linalool-enriched cannabis strains beneficial.

Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review

https://pubmed.ncbi.nlm.nih.gov/34544345/

Linalool Action on the Pathophysiological Factors of Depression

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886818/

Linalool Action in Monoaminergic System

Linalool Action on Stress, HPA Axis Modulation, and the Neuroendocrine System

Linalool Action on the Inflammatory Process

Linalool Action on Oxidative Stress

Linalool Action in BDNF and Neurotrophic Theory of Depression 9. Linalool Versus the Microbiota-gut-brain Axis 10. Linalool Action in the Glutamatergic System

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886818/

Linalool bioactive properties and potential applicability in drug delivery systems The present review focuses on the anti-inflammatory, anticancer, anti-hyperlipidemic, antimicrobial, antinoceptive, analgesic, anxiolytic, antidepressive and neuroprotective properties of linalool. The advantages of the loading in nanotechnology-based drug delivery systems, with the purpose of enhancing its bioactive properties are also discussed.

https://pubmed.ncbi.nlm.nih.gov/30098535/